Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PIK3R4 Monoclonal Antibody (5H3A11)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA538596
Description
This antibody has been tested in indirect ELISA.
Regulatory subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of autophagosomes and endocytosis. Involved in regulation of degradative endocytic trafficking and cytokinesis, probably in the context of PI3KC3-C2 (PubMed:20643123). [UniProt].
Specifications
PIK3R4 | |
Monoclonal | |
1 mg/mL | |
PBS with 0.05% sodium azide | |
Q99570 | |
PIK3R4 | |
Purified recombinant fragment of human PIK3R4 (aa: 772-906) expressed in E. Coli. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG2a |
Flow Cytometry, Immunohistochemistry, Western Blot, Immunocytochemistry | |
5H3A11 | |
Unconjugated | |
PIK3R4 | |
2210010O15Rik; C730038E05Rik; C85833; D9Ertd418e; p150; phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 4, p150; phosphatidylinositol 3-kinase-associated p150; phosphoinositide 3-kinase adaptor protein; Phosphoinositide 3-kinase regulatory subunit 4; phosphoinositide-3-kinase regulatory subunit 4; phosphoinositide-3-kinase, regulatory subunit 4; phosphoinositide-3-kinase, regulatory subunit 4, p150; PI3-Kinase p150; PI3-kinase p150 subunit; PI3-kinase regulatory subunit 4; PI3-kinase VPS15; PIK3R4; VPS15 | |
Mouse | |
Protein G | |
RUO | |
30849 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction